Governor Wes Moore just greenlit a big step for psychedelic reform in Maryland. He signed bills on Tuesday to keep the state’s psychedelics task force running until the end of 2027. This move charges the group with fresh ideas on therapy access and rules for wider use.
Wes Moore, Maryland’s Democratic governor, approved Senate Bill 336 and House Bill 427 on April 28, 2026. These laws stretch the Maryland Task Force on Responsible Use of Natural Psychedelic Substances through December 31, 2027. Lawmakers Sen. Brian Feldman and Del. Pam Guzzone led the push.
The bills add a new member from a historically Black college or university. They also demand an updated report by October 31, 2026. This report will offer more advice on safe access to substances like psilocybin from magic mushrooms.
Support came easy in the legislature. The Senate passed the measure without a single no vote. The House backed it strongly too. No big fights broke out over the plan.
This keeps momentum alive after the task force’s first big report last year.
Roots of the Psychedelics Task Force
Lawmakers created the task force back in 2024. Bills HB 548 and SB 1009 set it up under the Maryland Cannabis Administration. Governor Moore signed those into law that May.
The group has 19 volunteers. Experts in research, health, veterans’ issues, and policy reform fill the seats. Andrew Coop, a professor at the University of Maryland School of Pharmacy, chairs it. They held over 100 meetings and logged more than 700 hours of work.
Natural psychedelics top the list. Think psilocybin and psilocin from mushrooms, mescaline from cacti, and DMT from plants. Synthetics stay out.
| Key Timeline for Maryland Psychedelics Task Force |
|---|
| May 2024: Task force created |
| Oct/Nov 2025: First report released |
| April 2026: Extension bills signed |
| Oct 2026: Updated report due |
| Dec 2027: Task force ends |
This table shows the steady build toward real change.
Key Findings from the 2025 Report
The task force dropped its first report in October 2025. It used a smart method called modified Delphi to check 90 policy ideas. Johns Hopkins economists helped study economic impacts.
Natural psychedelics proved safe and helpful for many. They aid mental health woes like depression, PTSD, and chronic pain. Low links to crime or overdoses stood out. Poison center calls rose a bit with more use, but guided sessions cut risks.
Public interest grows fast. Twelve other states now study similar paths. Oregon and Colorado lead with decriminalization and therapy centers.
The report skipped waiting for FDA nods. Psilocybin got breakthrough status for tough depression cases, but federal rules lag.
One short note. Equity matters most here.
Phased Plan for Safe Access
The report pushes an “Ensemble Model.” It blends therapy, personal use, and sales with strong safety nets.
Here are the three phases:
- Phase 1: Set up a safety board. Train staff, track data, teach the public, and ease old convictions.
- Phase 2: Roll out supervised therapy spots and home growing. Boost research too.
- Phase 3: Open shops after proof it works well. Add more substances if ready.
This starts with psilocybin. It honors Indigenous traditions and small businesses. No rush to copy others where markets went gray.
Del. Pam Guzzone said it right. Change will take years, not days. Leaders stress “do no harm” first.
Veterans get early help. A 2024 fund covers free sessions for PTSD and brain injuries.
Impacts on Health and Daily Lives
Maryland folks stand to gain big. Imagine therapy for stubborn depression without endless pills. Thousands battle mental health daily. Psychedelics offer hope where others fail.
Workers in fire services and vets push for access. They see relief from trauma. Small farms could sprout, creating jobs.
Risks exist. Bad trips or mixes with meds worry experts. That’s why phases build slow.
Other states watch close. Maryland joins a wave. Colorado’s centers treat hundreds. Oregon reports fewer ER visits with rules.
Data from Johns Hopkins shows rising calls to poison centers. But pro guidance flips that.
This affects you. If stress hits hard, new options loom. Families see loved ones heal.
Change sparks debate. Some fear youth use. Others cheer breakthroughs.
The task force eyes broad reach. Affordable care for all, not just rich folks.
Maryland leads with care. It balances hope and caution.
As this psychedelics journey unfolds, Maryland sets a model for smart reform. Families heal, minds clear, and futures brighten from tough shadows.
